Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: fred hayes who wrote (3503)	11/6/2002 5:49:01 PM
From: Qualified Opinion	Respond to of 10345

Article addressed the new rules > limk Link:http://www.siliconinvestor.com/readmsg.aspx?msgid=18139945

To: fred hayes who wrote (3503)	11/6/2002 5:52:04 PM
From: Icebrg	Read Replies (2) \| Respond to of 10345

Fred This is the first time I come across this type of generic threat in one of my investments, so things are not entirely clear to me. Having said that it seems from the excerpt I posted, that Elan will enjoy at least a 30 month "grace" period while things are sorted out. After that the possibility remains that the patent will actually hold. 30 months is actually much better than what I had hoped for. I was afraid that we might face a Zanaflex-like situation where the market would be lost from one month to another. A 30 months grace window (if I have read this thing correctly) will provide Elan with much needed income over the critical restructuring period. It should give management time to sort out both the income and cost sides (I hope). Erik